Tacita Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.3K Hold
1,200
0.04% 117
2025
Q4
$114K Hold
1,200
0.07% 100
2025
Q3
$117K Hold
1,200
0.07% 94
2025
Q2
$129K Hold
1,200
0.08% 96
2025
Q1
$121K Hold
1,200
0.09% 94
2024
Q4
$107K Hold
1,200
0.08% 97
2024
Q3
$101K Hold
1,200
0.07% 102
2024
Q2
$92.4K Hold
1,200
0.07% 104
2024
Q1
$82.2K Hold
1,200
0.06% 117
2023
Q4
$69.4K Hold
1,200
0.05% 119
2023
Q3
$63.4K Hold
1,200
0.05% 133
2023
Q2
$65K Hold
1,200
0.05% 122
2023
Q1
$60K Hold
1,200
0.05% 122
2022
Q4
$56K Hold
1,200
0.04% 119
2022
Q3
$46K Hold
1,200
0.04% 126
2022
Q2
$45K Hold
1,200
0.03% 138
2022
Q1
$53K Hold
1,200
0.03% 143
2021
Q4
$51K Hold
1,200
0.03% 143
2021
Q3
$52K Hold
1,200
0.03% 133
2021
Q2
$51K Buy
+1,200
New +$50.5K 0.03% 143

Other funds holding BSX

Tacita Capital's BSX Position: Q1 2026 in Review

Tacita Capital held its Boston Scientific (BSX) position steady in Q1 2026 at 1,200 shares worth $75.3K. The position accounts for 0.04% of the portfolio, ranked #117.

Tacita Capital first reported a position in BSX in Q2 2021 and has held it in 20 quarters since. The position peaked at $129K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tacita Capital held 1,200 shares of Boston Scientific worth $75.3K as of Q1 2026.
  • Tacita Capital left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.04% of Tacita Capital's portfolio in Q1 2026, its #117 holding.
  • Tacita Capital first reported a position in Boston Scientific in Q2 2021 and has held it in 20 quarters since.
  • Tacita Capital's Boston Scientific position peaked at $129K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.